Previous close | 16.59 |
Open | 16.20 |
Bid | 16.20 x 400 |
Ask | 16.27 x 400 |
Day's range | 15.80 - 16.50 |
52-week range | 13.48 - 39.50 |
Volume | |
Avg. volume | 641,733 |
Market cap | 1.625B |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
With the business potentially at an important milestone, we thought we'd take a closer look at Zai Lab Limited's...
As an investor, mistakes are inevitable. But really bad investments should be rare. So take a moment to sympathize with...
Zai Lab Ltd (NASDAQ:ZLAB), a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for cancer, autoimmune, and infectious diseases, has reported an insider sale according to a recent SEC filing.